Chin-Sung Kuo

Chin-Sung Kuo

Auto-generated profile, based on publicly available information

Chin-Sung Kuo

Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RCRuey-Hsing Chou
Ruey-Hsing Chou
CCChi-Yu Chen
Chi-Yu Chen
ICI-Chun Chen
I-Chun Chen
HHHsin-Lei Huang
Hsin-Lei Huang
YLYa-Wen Lu
Ya-Wen Lu
SLShing-Jong Lin
Shing-Jong Lin
Trimethylamine N-oxide (TMAO) is a metabolite originated from bacterial metabolism of choline-rich foods. Evidence suggests an association between TMAO and atherosclerosis, but the relationship between TMAO and endothelial progenitor cells (EPCs) remains unclear. This study aimed to identify the relationship between TMAO concentrations, circulating EPCs, and endothelial function in patients with stable angina. Eighty-one stable angina subjects who underwent coronary angiography were enrolled. The circulating EPCs and flow-mediated vasodilation (FMD) were measured to evaluate endothelial function. Plasma TMAO and inflammatory markers, such as hsCRP and IL-1β, were determined. Furthermore, the effect of TMAO on EPCs was assessed in vitro. Patients with lower FMD had significantly decreased circulating EPCs, elevated TMAO, hsCRP, and IL-1β concentrations. Plasma TMAO levels were negatively correlated with circulating EPC numbers and the FMD, and positively correlated with hsCRP, IL-1β concentrations. In in vitro studies, incubation of TMAO in cultured EPCs promoted cellular inflammation, elevated oxidative stress, and suppressed EPC functions. Enhanced plasma TMAO levels were associated with reduced circulating EPCs numbers, endothelial dysfunction, and more adverse cardiovascular events. These findings provided evidence of TMAO’s toxicity on EPCs, and delivered new insight into the mechanism of TMAO-mediated atherosclerosis, which could be derived from TMAO-downregulated EPC functions.

27 March 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CCChun-Chin Chang
Chun-Chin Chang
CWCheng-Hsueh Wu
Cheng-Hsueh Wu
LLLi-Kuo Liu
Li-Kuo Liu
RCRuey-Hsing Chou
Ruey-Hsing Chou
CKChin-Sung Kuo
Chin-Sung Kuo
SLShing-Jong Lin
Shing-Jong Lin
Serum uric acid level is a risk factor for cardiovascular disease (CVD). However, whether it is an independent risk factor or not remains controversial. We analyzed the association between serum uric acid level and cardiovascular risk. In total, 973 nonhypertensive and nondiabetic participants in the I-Lan Longitudinal Aging Study were eligible for this study. Subjects were divided into tertiles according to uric acid levels. The 10-year cardiovascular risk was calculated using Framingham risk score (FRS). Study subjects in the highest tertile of serum uric acid level were older, more likely to be male, and had higher systolic blood pressure, body mass index, carotid artery intima–media thickness and serum triglyceride, high-sensitivity C-reactive protein, and low-density lipoprotein cholesterol levels and lower serum high-density lipoprotein cholesterol levels (all p < 0.05). Subjects in the highest tertile had significantly higher FRS (p < 0.001). After adjusting for other risk factors, serum uric acid level remained associated significantly with the FRS (p < 0.05). In binary logistic regression analysis, the serum uric acid level was an independent predictive factor for high (≥20%) FRS (odds ratio 1.33, 95% confidence interval 1.10–1.68). These findings warrant attention to this cardiovascular risk factor in apparently healthy adults.

1 May 2021 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
YLYa-Wen Lu
Ya-Wen Lu
YTYi-Lin Tsai
Yi-Lin Tsai
RCRuey-Hsing Chou
Ruey-Hsing Chou
CKChin-Sung Kuo
Chin-Sung Kuo
CCChun-Chin Chang
Chun-Chin Chang
SLShing-Jong Lin
Shing-Jong Lin

15 December 2006 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
YHYu‐Hsi Hsieh
Yu‐Hsi Hsieh
CKChin‐Sung Kuo
Chin‐Sung Kuo
KTKuo‐Chih Tseng
Kuo‐Chih Tseng
HLHwai‐Jeng Lin
Hwai‐Jeng Lin

1 October 2019 in Clinical Nutrition
Verified
Journal Article
Closed access
YLYa-Wen Lu
Ya-Wen Lu
SLShu-Fen Lu
Shu-Fen Lu
RCRuey-Hsing Chou
Ruey-Hsing Chou
PWPo-Shan Wu
Po-Shan Wu
YKYu-Chen Ku
Yu-Chen Ku
PHPo-hsun Huang
Po-hsun Huang

29 January 2004 in European Journal of Clinical Nutrition
Verified
Journal Article
Closed access
CKC-S Kuo
C-S Kuo
NLN-S Lai
N-S Lai
LHL-T Ho
L-T Ho
CLC-L Lin
C-L Lin